Cargando…
Potentiating antitumor immunity with αGC-loaded exosomes
Anticancer immunotherapy is a promising treatment modality since it bears the potential of being highly specific, but effective clinical applications are still under development. We have recently described an exosome-based strategy for co-delivery of α-galactosylceramide and a tumor-associated antig...
Autores principales: | Gehrmann, Ulf, Hiltbrunner, Stefanie, Näslund, Tanja I, Gabrielsson, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862686/ https://www.ncbi.nlm.nih.gov/pubmed/24353911 http://dx.doi.org/10.4161/onci.26261 |
Ejemplares similares
-
Cancer immunotherapy with exosomes requires B-cell activation
por: Näslund, Tanja I, et al.
Publicado: (2013) -
Soluble and Exosome-Bound α-Galactosylceramide Mediate Preferential Proliferation of Educated NK Cells with Increased Anti-Tumor Capacity
por: Wagner, Arnika K., et al.
Publicado: (2021) -
Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivo
por: Wahlund, Casper J. E., et al.
Publicado: (2017) -
Polyamine blockade promotes antitumor immunity
por: Hayes, Candace S, et al.
Publicado: (2014) -
Retinoic acid on stage in antitumor immunity
por: Guo, Yanxia, et al.
Publicado: (2013)